366 related articles for article (PubMed ID: 28838382)
1. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
Gagliasso M; Migliaretti G; Ardissone F
Lung Cancer; 2017 Sep; 111():124-130. PubMed ID: 28838382
[TBL] [Abstract][Full Text] [Related]
2. Complete resection in lung cancer surgery: proposed definition.
Rami-Porta R; Wittekind C; Goldstraw P;
Lung Cancer; 2005 Jul; 49(1):25-33. PubMed ID: 15949587
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
4. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
7. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
8. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
[TBL] [Abstract][Full Text] [Related]
9. Surgical Treatment of Superior Sulcus Tumors: A 15-Year Single-center Experience.
Solli P; Casiraghi M; Brambilla D; Maisonneuve P; Spaggiari L
Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):79-88. PubMed ID: 28684003
[TBL] [Abstract][Full Text] [Related]
10. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
[TBL] [Abstract][Full Text] [Related]
12. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
13. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump.
Ghiribelli C; Voltolini L; Paladini P; Luzzi L; Di Bisceglie M; Gotti G
Eur J Cardiothorac Surg; 1999 Nov; 16(5):555-9. PubMed ID: 10609907
[TBL] [Abstract][Full Text] [Related]
14. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
15. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
17. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
18. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
19. The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer.
Sawabata N; Keller SM; Matsumura A; Kawashima O; Hirono T; Osaka Y; Maeda H; Fukai S; Kawahara M;
Lung Cancer; 2003 Oct; 42(1):69-77. PubMed ID: 14512190
[TBL] [Abstract][Full Text] [Related]
20. Surgical Outcomes after Pulmonary Resection for Non-Small Cell Lung Cancer with Localized Pleural Seeding First Detected during Surgery.
Yun JK; Kim MA; Choi CM; Choi SH; Kim YH; Kim DK; Park SI; Kim HR
Thorac Cardiovasc Surg; 2018 Mar; 66(2):142-149. PubMed ID: 26669768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
